Predatory bacteria: a new therapeutic approach for a post-antibiotic era


Antibiotics are primarily responsible for the sharp decline of infectious disease-related deaths caused by bacteria over the past 50 years. However, due to the overuse and misuse of antibiotics, among other reasons, the rise of multidrug-resistant (MDR) bacterial infections over the last decade now represents a serious threat to public health. The CDC estimates over 2 million people are infected and more than 23,000 die annually in the USA as a direct result of an MDR infection [1]. Compounding this issue is the fact that an antibiotic discovery void over the past 30 years has resulted in a current shortage in the antibiotic development pipeline.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.



Leave A Comment